Establishment of hormone reference intervals for infants born <30weeks' gestation

Clinical Biochemistry

Volumn 47, Issue 15, 2014, Pages 101-108

  Greaves, Ronda F ^a,b   Zacharin, Margaret R ^b,c,d   Donath, Susan M ^b,c   Inder, Terrie E ^b,e   Doyle, Lex W ^b,c,f   Hunt, Rodney W ^b,c,d  

^a RMIT UNIVERSITY   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Cortisol; DHEAS; Growth hormone; Prematurity; Thyroxine

Indexed keywords

ESTRADIOL; GROWTH HORMONE; HORMONE; HYDROCORTISONE; PRASTERONE SULFATE; PROGESTERONE; SOMATOMEDIN C; THYROXINE;

AGE DISTRIBUTION; ANALYZER; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; ESTRADIOL BLOOD LEVEL; FEMALE; FREE THYROXINE INDEX; GESTATIONAL AGE; HORMONE DETERMINATION; HUMAN; INFANT; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREMATURITY; REFERENCE VALUE; TANDEM MASS SPECTROMETRY; BLOOD; ENDOCRINE SYSTEM; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN; PATHOLOGY;

DEHYDROEPIANDROSTERONE SULFATE; ENDOCRINE SYSTEM; ESTRADIOL; FEMALE; GESTATIONAL AGE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN-LIKE GROWTH FACTOR I; MALE; PROGESTERONE; REFERENCE VALUES; THYROXINE;

EID: 84910039025     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.06.002     Document Type: Article

References (32)

1. Li Z., Zeki R., Hilder L., Sullivan E.A. Australia's mothers and babies 2010. Perinatal statistics series no. 27. Cat. no. PER 57 2012, AIHW National Perinatal Epidemiology and Statistics Unit, Canberra, (www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129542372, (accessed 1st December 2013)).
2. Blencowe H., Cousens S., Oestergaard M.Z., Chou D., Moller A.-B., Narwal R., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012, 379:2162-2172.
3. Halliday H.L., Ehrenkranz R.A., Doyle L.W. Early (<8days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev Jan 21 2009, (1):CD001146. 10.1002/14651858.CD001146.pub2.
4. National Health and Medical Research Council Care around preterm birth. Clinical practice guidelines 1997, Australian Government Publishing Service.
5. Anderson P.J., Doyle L.W. Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s. JAMA 2003, 289:3264-3272. The Victorian Infant Collaborative Study Group.
6. Doyle L.W., Anderson P.J. Adult outcomes of extremely preterm infants. Pediatrics 2010, 126:342-351.
7. Herz K., Wohlmuth P., Liedtke B., Schmidt S., Hackelöer B.J., Hellmeyer L. Late preterms: the influence of foetal gender on neonatal outcome. Z Geburtshilfe Neonatol 2012, 216(3):141-146. [Abstract only in English Article in German].
8. Ranke M.B. Diagnostics of endocrine function in children and adolescents 2011, Karger, Basel. 4th ed.
9. Bolt R.J., van Weissenbruch M.M., Popp-Snijders C., Sweep C.G.J., Lafeber H.N., Delemarre-van de Waal H.A. Fetal growth and the function of the adrenal cortex in preterm infants. J Clin Endocrinol Metabol 2002, 87:1194-1199.
10. Van Wassenaer A.G., Kok J.H., Briet J.M., Pijning A.M., de Vijlder J.J. Thyroid function in very preterm newborns: possible implications. Thyroid 1999, 9:85-91.
11. Rooman R.P., Du Caju M.V.L., De Beeck L.O., Docx M., Van Reempts P., Van Acker K.J. Low thyroxinaemia occurs in the majority of very preterm newborns. Eur J Pediatr 1996, 155:211-215.
12. Midgley P.C., Russell K., Oates N., Shaw J.C., Honour J.W. Activity of the adrenal fetal zone in preterm infants continues to term. Endocr Res 1996, 22:729-733.
13. Greaves R.F., Hunt R.W., Chiriano A.S., Zacharin M.R. Luteinizing hormone and follicle-stimulating hormone levels in extreme prematurity: development of reference intervals. Pediatrics 2008, 121:e574-e580.
14. Ng S.M., Turner M.A., Gamble C., Didi M., Victor S., Malamateniou C., et al. TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28weeks gestation: Magnetic resonance imaging and magnetic resonance angiography protocol. BMC Pediatr 2008, 8:26-33.
15. Beyer C. Estrogen and the developing mammalian brain. Anat Embryol 1999, 199:379-390.
16. Trotter A., Bokelmann B., Sorgo W., Bechinger-Kornhuber D., Heinemann H., Schmucker G., et al. Follow-up examination at the age of 15months of extremely preterm infants after postnatal estradiol and progesterone replacement. J Clin Endocrinol Metabol 2001, 86:601-603.
17. Osborn D.A., Hunt R.W. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. (Review). Cochrane Database Syst Rev 2006, (2). [Art. No.: CD005948]. 10.1002/14651858.CD005948.
18. Hunt R.W., Davis P.G., Inder T.E. Replacement of estrogens and progestins to prevent morbidity and mortality in preterm infants (Cochrane review). The Cochrane library 2004, Issue 4.
19. Greaves R., Hunt R.W., Zacharin M. Transient anomalies in genital appearance in some extremely preterm female infants may be the result of foetal programming causing a surge in LH and the over activation of the pituitary-gonadal axis. Clin Endocrinol (Oxf) 2008, 69:763-768.
20. Verras P., Greaves R. Abnormal laboratory results: important issues to consider in the interpretation of paediatric biochemistry. Aust Prescriber 2005, 28:126-129.
21. Verras P., Greaves R. Interpreting paediatric biochemistry results. Australian prescriber: abnormal laboratory results 2011, McGraw-Hill, Australia. 3rd ed.
22. Greaves R., Kanumakala S., Read A., Zacharin M. Transient 3 beta HSD deficiency and ambiguous genitalia in premature babies. J Paediatr Child Health 2004, 40:233-236.
23. Pařízeka A., Kouckýa M., Duškováb M. Progesterone, inflammation and preterm labor. J Steroid Biochem Mol Biol 2014, 139:159-165. [in press]. 10.1016/j.jsbmb.2013.02.00.
24. Roberts D., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, (3). [Art.No.: CD004454]. 10.1002/14651858.CD004454.pub2.
25. Seimens Healthcare Immulite 2000 - Cortisol package insert 1999.
26. Davis E.P., Waffarn F., Sandman C.A. Prenatal treatment with glucocorticoids sensitizes the hpa axis response to stress among full-term infants. Dev Psychobiol 2011, 53:175-183.
27. Gatelais F., Berthelot J., Beringue F., Descamps P., Bonneau D., Limal J.-M., et al. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia. Pediatr Res 2004, 56:701-705.
28. Williams F.I., Simpson J., Delahunty C., Ogston S.A., Bongers-Schokking J.J., Murphy N., et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metabol 2004, 89:5314-5320.
29. Mercado M., Yu V.Y., Fancis I., Szymonowicz W., Gold H. Thyroid function in very preterm infants. Early Hum Dev 1988, 16:131-141.
30. Wang R., Nelson J.C., Weiss R.M., Wilcox R.B. Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid 2000, 10:31-39.
31. Quigley C.A. The postnatal gonadotropin and sex steroid surge - insights from the androgen insensitivity syndrome. J Clin Endocrinol Metabol 2002, 87(1):24-28.
32. Greaves R.F. A guide to harmonisation and standardisation of measurands determined by liquid chromatography-tandem mass spectrometry in routine clinical biochemistry. Clin Biochem Rev 2012, 33:123-132.